Dr. Laura Esserman is an internationally recognized breast surgeon, breast oncology specialist, and visionary in personalized medicine, revolutionizing breast cancer screening and treatment throughout the United States. Here’s the thing: How we approach care, treatment, and even prevention is backward and doesn’t provide individualized care to a woman as she needs it. As a Professor of Surgery and Radiology at the University of California, San Francisco (UCSF) and the Director of the UCSF Breast Care Center, Esserman is a provocative thought leader who draws attention to and seeks solutions for the overdiagnosis and overtreatment of breast cancer, particularly DCIS.
Since 2002, Dr. Esserman has led the I-SPY TRIALS, a groundbreaking national public-private collaboration among the NCI, FDA, more than 20 cancer research centers, and major pharmaceutical and biotech companies, as well as the not-for-profit sponsor, Quantum Leap Healthcare Collaborative. This trial model, which has now become an international model for translational research, is designed to shave several years and tens of millions of dollars off the drug development process. Don’t miss this critical conversation everyone should hear. After all, we’ve all been touched by cancer and this vital information may change the way you view it or receive care.
This is a very informative interview that will change the way you see breast cancer (prevention) and treatment.
WATCH the interview with Dr. Laura Esserman. Also, subscribe to our FREE YouTube Channel Blue Soul Earth and Blue Soul CHATS Podcast.